日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Resilience and residuals beyond containment - The hidden burden of Bundibugyo Ebola virus survivorship sixteen years on: A cross-sectional observational study

疫情控制之外的韧性和遗留问题——邦迪布焦埃博拉病毒幸存者十六年后的隐性负担:一项横断面观察研究

Kaweesa, Raymond Ernest; Katende, Joseph Ssebwana; Wayesu, Raymond Reuel; Ntabadde, Annie Daphine; Opio, Solomon; Kato, Laban; Oluka, Gerald Kevin; Nambi, Ruth; Tumusiime, Rodney Abraham; Kaleebu, Pontiano; Lutwama, Julius Julian; Serwanga, Jennifer

Neutralization and ADCC reveal divergent spike-subdomain targeting across SARS-CoV-2 vaccine platforms in an African cohort.

中和作用和ADCC揭示了非洲人群中不同SARS-CoV-2疫苗平台对刺突蛋白亚结构域的靶向作用存在差异。

Oluka Gerald Kevin, Katende Joseph Ssebwana, Kato Laban, Ankunda Violet, Sembera Jackson, Ejou Peter, Odoch Geoffrey, Namuyanja Angella, Kaleebu Pontiano, Serwanga Jennifer

Two Decades Later: Long-Term Multisystem Sequelae and Subclinical Organ Dysfunction in Sudan Ebola Virus (SUDV) Survivors of the 2000 Outbreak

二十年后:2000年苏丹埃博拉病毒(SUDV)疫情幸存者的长期多系统后遗症和亚临床器官功能障碍

Kaweesa, Raymond Ernest; Katende, Joseph Ssebwana; Odoch, Geoffrey; Ntabadde, Annie Daphine; Wayesu, Raymond Reuel; Mukisa, Deborah; Ejou, Peter; On Behalf Of The FiloStudy Team; Kaleebu, Pontiano; Serwanga, Jennifer

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda Comparison.

SARS-CoV-2 抗体反应动态和对轻症 COVID-19 的中和特征的地域差异:来自英国和乌干达的比较经验

Kato Laban, Sembera Jackson, Oluka Gerald Kevin, Katende Joseph Ssebwana, Bemanzi Juliana, Ankunda Violet, Ejou Peter, Kurshan Ashwini, Graham Carl, Seow Jeffrey, Doores Katie J, Malim Michael H, Fox Julie M, Kaleebu Pontiano, Serwanga Jennifer

Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals.

SARS-CoV-2 刺突糖蛋白编码的改良型自扩增核糖核酸 (saRNA) 疫苗在 SARS-CoV-2 血清阴性和血清阳性乌干达个体中的安全性和免疫原性

Kitonsa Jonathan, Serwanga Jennifer, Cheeseman Hannah M, Abaasa Andrew, Lunkuse Jane Frances, Ruzagira Eugene, Kato Laban, Nambaziira Florence, Oluka Gerald Kevin, Gombe Ben, Jackson Sembera, Ssebwana Joseph Katende, McFarlane Leon R, Joseph Sarah, Pierce Benjamin F, Shattock Robin J, Kaleebu Pontiano

Thirteen-Year Sequelae of Marburg Virus Disease Survival: Persistent Cardiometabolic, Immunometabolic, and Haematological Alterations in the Absence of Psychological Morbidity

马尔堡病毒病幸存者十三年后的后遗症:在无心理疾病的情况下持续存在的心血管代谢、免疫代谢和血液学改变

Serwanga, Jennifer; Kaweesa, Raymond Ernest; Ssebwana, Joseph Katende; Odoch, Goeffrey; Wayesu, Raymond Reuel; Ntabadde, Anne Daphine; Mukisa, Deborah; Ejou, Peter; FiloStudy Team; Lutwama, Julius Julian; Kaleebu, Pontiano

Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa

HIV-CORE 006 研究:在东非和南部非洲健康成年人中开展的一项双盲、随机、安慰剂对照的 1 期临床试验,评估了由 ChAdOx1 和 MVA 载体递送的 HIVconsvX 保守嵌合候选 T 细胞疫苗的安全性和广泛免疫原性。

Chanda, Chama; Kibengo, Freddie; Mutua, Michael; Ogada, Fred; Muturi-Kioi, Vincent; Akis Yildirim, Belkis M; Amondi, Mary; Baines, Andrea; Basajja, Vincent; Borthwick, Nicola; Bosire, Kefa; Chambula, Elias; Chetty, Paramesh; Chinyenze, Kundai; Chirro, Oscar; Crook, Alison; De Bont, Jan; Fernandez, Natalia; Ejou, Peter; Farah, Bashir; Glaze, Molly; Gombe, Ben; Gumbe, Anne; Hayes, Peter; Itwi, Sally; Juma, Sheba; Kabarambi, Anita; Kabengele, Chishiba; Kafeero, Paddy; Kakande, Ayoub; Kanungi, Jennifer; Kidega, William; King, Deborah; Mahira, Rose; Malogo, Roselyn; Matsoso, Mabela; Michelo, Clive; Moyo, Annie; Mugaba, Susan; Mugenya, Irene; Muhumuza, Patrick; Mujadidi, Yama F; Muriuki, Moses; Musale, Vernon; Mutua, Gaudensia; Muwowo, Meya; Mwale, Fatima; Mwangi, Irene; Nakimbugwe, Maria; Namuyanja, Angella; Nduati, Eunice; Nielsen, Leslie; Nyange, Jaquelyn; Oino, Geofrey; Okech, Brenda; Omosa-Manyonyi, Gloria; Otieno, Dan; Palmer, Shaun; Phiri, Hilda; Ramko, Kelly; Rutishauser, Rachel L; Sayeed, Eddy; Sajabi, Rose; Serwanga, Jennifer; G-T Wee, Edmund; Wenden, Claire; Cicconi, Paola; Fast, Patricia; Gilmour, Jill; Jaoko, Walter; Kaleebu, Pontiano; Kilembe, William; Kuipers, Hester; Sanders, Eduard J; Hanke, Tomáš

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies

乌干达接种辉瑞-BioNTech BNT162b2疫苗后,加强免疫后针对刺突蛋白的二次IgG抗体反应较弱,这对当地的疫苗接种政策具有重要意义。

Ankunda, Violet; Katende, Joseph Ssebwana; Oluka, Gerald Kevin; Sembera, Jackson; Baine, Claire; Odoch, Geoffrey; Ejou, Peter; Kato, Laban; Kaleebu, Pontiano; Serwanga, Jennifer

Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations

撒哈拉以南非洲人群中针对 Moderna mRNA-1273 疫苗的持续性 S-IgG 和 S-IgA 抗体表明,需要重新考虑加强免疫接种时间。

Serwanga, Jennifer; Ankunda, Violet; Katende, Joseph Ssebwana; Baine, Claire; Oluka, Gerald Kevin; Odoch, Geoffrey; Nantambi, Hellen; Mugaba, Susan; Namuyanja, Angella; Ssali, Ivan; Ejou, Peter; Kato, Laban; Musenero, Monica; Kaleebu, Pontiano

Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles

在乌干达不同基线免疫特征的人群中,均观察到对牛津-阿斯利康(ChAdOx1-S,Covishield)SARS-CoV-2疫苗ChAdOx1-S的持续且强效的抗体反应。

Serwanga, Jennifer; Oluka, Gerald Kevin; Baine, Claire; Ankunda, Violet; Sembera, Jackson; Kato, Laban; Katende, Joseph Ssebwana; Odoch, Geoffrey; Auma, Betty Oliver; Gombe, Ben; Musenero, Monica; Kaleebu, Pontiano